134 related articles for article (PubMed ID: 29341447)
1. Anti-transcription intermediary factor 1γ antibody titer correlates with clinical symptoms in a patient with recurrent dermatomyositis associated with ovarian cancer.
Teraishi M; Nakajima K; Ishimoto T; Yamamoto M; Maeda N; Muro Y; Sano S
Int J Rheum Dis; 2018 Apr; 21(4):900-902. PubMed ID: 29341447
[No Abstract] [Full Text] [Related]
2. Anti-transcription intermediary factor-1γ/α/β antibody-positive dermatomyositis associated with multiple panniculitis lesions.
Yanaba K; Tanito K; Hamaguchi Y; Nakagawa H
Int J Rheum Dis; 2017 Nov; 20(11):1831-1834. PubMed ID: 26258542
[No Abstract] [Full Text] [Related]
3. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
Kubeček O; Soukup T; Paulík A; Kopecký J
BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis.
Venalis P; Selickaja S; Lundberg K; Rugiene R; Lundberg IE
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):648-651. PubMed ID: 28704599
[TBL] [Abstract][Full Text] [Related]
5. High grade serous ovarian carcinoma with serous tubal intraepithelial carcinoma in a case presented with atypical glandular cell favor neoplasm cervical cytology and dermatomyositis.
Hong MK; Lee MH; Ding DC; Chu SC; Chu TY
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):183-6. PubMed ID: 25951725
[TBL] [Abstract][Full Text] [Related]
6. [Dermatomyositis and punctate porokeratotic keratoderma as paraneoplastic syndrome of ovarian carcinoma].
Valverde R; Sánchez-Caminero MP; Calzado L; Ortiz de Frutos FJ; Rodríguez-Peralto JL; Vanaclocha F
Actas Dermosifiliogr; 2007 Jun; 98(5):358-60. PubMed ID: 17555681
[TBL] [Abstract][Full Text] [Related]
7. Dermatomyositis as first presentation of ovarian cancer.
Venhuizen AC; Martens JE; van der Linden PJ
Acta Obstet Gynecol Scand; 2006; 85(10):1271-2. PubMed ID: 17068691
[No Abstract] [Full Text] [Related]
8. Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung disease.
Taggart AJ; Finch MB; Courtney PA; Gormley GJ
Ulster Med J; 2002 May; 71(1):68-71. PubMed ID: 12137171
[No Abstract] [Full Text] [Related]
9. RS3PE and ovarian cancer.
Vinci M; Malaguarnera L; Pistone G
Ann Rheum Dis; 2001 Apr; 60(4):429-31. PubMed ID: 11284457
[No Abstract] [Full Text] [Related]
10. Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Kono M; Akiyama M
Clin Exp Rheumatol; 2018; 36(6):990-995. PubMed ID: 29745874
[TBL] [Abstract][Full Text] [Related]
11. Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.
Best M; Molinari N; Chasset F; Vincent T; Cordel N; Bessis D
Acta Derm Venereol; 2019 Mar; 99(3):256-262. PubMed ID: 30460368
[TBL] [Abstract][Full Text] [Related]
12. First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome.
Palterer B; Vitiello G; Cammelli D
Reumatismo; 2017 Aug; 69(2):75-77. PubMed ID: 28776361
[TBL] [Abstract][Full Text] [Related]
13. A diagnostic dilemma: A rare case of an ovarian carcinoma with signet ring cells hidden behind a substantial dermatomyositis.
Aydin AA; Ayik H; Onder AH; Ozturk B; Yildiz M
J Cancer Res Ther; 2019; 15(6):1395-1397. PubMed ID: 31898679
[TBL] [Abstract][Full Text] [Related]
14. Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
Aritomi T; Kido T; Nakano K; Satoh Y; Noguchi S; Jotatsu T; Hanaka T; Satoh M; Tanaka Y; Yatera K
Intern Med; 2019 Feb; 58(3):427-431. PubMed ID: 30210109
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic dermatomyositis presenting myopathy combined with synchronous cervical and sigmoid colon cancer.
Chung JH; So MW; Kim SG
Korean J Intern Med; 2016 Mar; 31(2):413-6. PubMed ID: 26828248
[No Abstract] [Full Text] [Related]
16. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.
Rogers A; Chung L; Li S; Casciola-Rosen L; Fiorentino DF
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1909-1914. PubMed ID: 28129490
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic subacute cerebellar degeneration: case report].
Bardy FB; Cagy M; Pompeu Filho F; Lamarca JE; Rabinovitz M; Godoy JM
Arq Neuropsiquiatr; 2000 Sep; 58(3A):764-8. PubMed ID: 10973125
[TBL] [Abstract][Full Text] [Related]
18. Anti-TIF1-γ autoantibodies-positive dermatomyositis: where is the malignancy?
Zachou A; Zouvelou V; Papadimas GK; Rentzos M; Papadopoulos C
Rheumatology (Oxford); 2018 Apr; 57(4):756. PubMed ID: 28968891
[No Abstract] [Full Text] [Related]
19. Ovarian cancer causing upper and lower urinary tract obstruction.
Geisler JP; Perry RW; Ayres GM; Holland TF; Melton ME; Geisler HE
Eur J Gynaecol Oncol; 1994; 15(5):343-4. PubMed ID: 7828602
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis associated with ovarian cancer.
Vílchez-Márquez F; Prieto-Llamas R; Sánchez-Sánchez G
Med Clin (Barc); 2017 May; 148(10):e55. PubMed ID: 27567332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
